DK0499586T3 - Substitueret benzofuranylpiperidin som nootropikum - Google Patents

Substitueret benzofuranylpiperidin som nootropikum

Info

Publication number
DK0499586T3
DK0499586T3 DK92810085.8T DK92810085T DK0499586T3 DK 0499586 T3 DK0499586 T3 DK 0499586T3 DK 92810085 T DK92810085 T DK 92810085T DK 0499586 T3 DK0499586 T3 DK 0499586T3
Authority
DK
Denmark
Prior art keywords
nootropic
benzofuranylpiperidine
substituted
treatment
disorders
Prior art date
Application number
DK92810085.8T
Other languages
Danish (da)
English (en)
Inventor
Cesare Dr Mondadori
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of DK0499586T3 publication Critical patent/DK0499586T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK92810085.8T 1991-02-15 1992-02-06 Substitueret benzofuranylpiperidin som nootropikum DK0499586T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH47091 1991-02-15

Publications (1)

Publication Number Publication Date
DK0499586T3 true DK0499586T3 (da) 1996-06-24

Family

ID=4187740

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92810085.8T DK0499586T3 (da) 1991-02-15 1992-02-06 Substitueret benzofuranylpiperidin som nootropikum

Country Status (16)

Country Link
EP (1) EP0499586B1 (es)
JP (1) JPH0570352A (es)
KR (1) KR920016098A (es)
AT (1) ATE138805T1 (es)
AU (1) AU655227B2 (es)
CA (1) CA2061015A1 (es)
DE (1) DE59206442D1 (es)
DK (1) DK0499586T3 (es)
ES (1) ES2087497T3 (es)
GR (1) GR3020155T3 (es)
IE (1) IE74906B1 (es)
IL (1) IL100889A (es)
MX (1) MX9200620A (es)
NO (1) NO179358C (es)
NZ (1) NZ241608A (es)
ZA (1) ZA921091B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3595093A (en) * 1992-02-21 1993-09-13 Ciba-Geigy Ag Brofaromine as an agent for treating social phobia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2938463B2 (ja) * 1987-10-22 1999-08-23 マサチユセツツ・インスチチユート・オブ・テクノロジー 月経前又は後期黄体期症候群の処置

Also Published As

Publication number Publication date
ZA921091B (en) 1992-09-30
EP0499586A1 (de) 1992-08-19
NO920591L (no) 1992-08-17
IE920486A1 (en) 1992-08-26
NZ241608A (en) 1997-06-24
KR920016098A (ko) 1992-09-24
NO179358C (no) 1996-09-25
NO920591D0 (no) 1992-02-14
GR3020155T3 (en) 1996-09-30
IE74906B1 (en) 1997-08-13
EP0499586B1 (de) 1996-06-05
IL100889A (en) 1997-03-18
IL100889A0 (en) 1992-11-15
JPH0570352A (ja) 1993-03-23
AU1087792A (en) 1992-08-20
CA2061015A1 (en) 1992-08-16
ES2087497T3 (es) 1996-07-16
MX9200620A (es) 1992-08-01
NO179358B (no) 1996-06-17
ATE138805T1 (de) 1996-06-15
DE59206442D1 (de) 1996-07-11
AU655227B2 (en) 1994-12-08

Similar Documents

Publication Publication Date Title
NO931056L (no) Sulfonamido- og sulfonamidokarbonyl-pyridin-2-karboksylsyreamider samt deres pyridin-n-oksider, fremgangsmaater for fremstilling derav og anvendelse av forbindelsene som legemidler
DK0574313T3 (da) 1,4-disubstituerede piperaziner til behandling af sygdomme i centralnervesystemet og neuroendocrine sygdomme
DK0633259T3 (da) Hidtil ukendte sulfonylaminopyrimidiner, fremstilling heraf og deres anvendelse som lægemidler
ATE211743T1 (de) Substituierte 3-aminochinuclidine
ES8705387A1 (es) Un procedimiento para preparar derivados de n-aril-n-(4-piperidinil)-alcoxialquilamida
FI962324A0 (fi) N-substituoituja atsabisykloalkaanijohdannaisia neuroleptisinä aineina ASF
DE69427704D1 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n-disubstituierte-amino-3,4-dihydro-2h-1-benzopyrane
GEP20022636B (en) 4-[5-Methyl-3-Phenylisoxazol-4-Yl] Benzenesulfonamide, Its Crystal Structure B, Pharmaceutical Composition Containing The Same, Methods For Treatment Or Prophylaxis Of Disorders Caused By Cyclooxygen-2
NO940523L (no) Nye pyrazin-derivater
NO980923L (no) Optisk aktivt fenylpyrimidin-derivat som analgetisk middel
IT1256320B (it) Derivati eterociclici
IL113411A (en) Pharmaceutical composition for the treatment or prophylaxis of hyperglycaemias comprising moxonidine as active ingredient and process for the production of such composition
DK0499586T3 (da) Substitueret benzofuranylpiperidin som nootropikum
NO982863L (no) Nye forbindelser med analgetisk effekt
DK0388298T3 (da) Azetidinylsubstituerede derivater af pyridoncarboxylsyrer, deres fremstilling og anvendelse som lægemidler
ES2081834T3 (es) Pirrolidin-2-onas 4-metil y 4-etil sustituidas.
BR0016516A (pt) Pirróis substituìdos
DK0590520T3 (da) Arylsulfonamido- og sulfonamidopyridin-2-carboxyl-syreestere samt deres pyridin-N-oxider, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
ES2001104A6 (es) Un procedimiento para la preparacion de nuevos derivados sustituidos del acido 1,4-dihidro-3,5-piridindicarboxilico.
AU4831279A (en) New compounds
DK0573360T3 (da) Pyrrolothienopyrazinforbindelser som 5-HT3-receptorantagonister